20 AIDX
NASDAQ AIDX
$0.51 +0.01 (+1.06%)
At close: Aug 20, 2026 · 2:07 PM UTC

20 (AIDX) Operating Expenses (2025 - 2026)

20's (AIDX) quarterly Operating Expenses came in at $1.5 million in Q1 2026, up 60.58% YoY from $937975.0 in Q1 2025, and up 60.58% on a QoQ basis from $937975.0 in Q1 2025.

20 (AIDX) Operating Expenses (2025 - 2026) Analysis & Trends

20 (AIDX) has 2 years of Operating Expenses data on file, last reported at $1.5 million in Q1 2026.

  • Quarterly Operating Expenses rose 60.58% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (changed N/A YoY) and the FY2025 annual result came in at $3.9 million, down 34.82% from the prior year.
  • Operating Expenses grew to $1.5 million in Q1 2026, from $937975.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.5 million in Q1 2026 to a low of $937975.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Abbott Laboratories 199.61 Bn 194.01 Bn 7.27 Bn 10.90 Bn
2 Stryker 127.81 Bn 124.34 Bn 4.50 Bn 2.84 Bn
3 Medtronic 119.04 Bn 109.82 Bn 6.41 Bn 3.59 Bn
4 Boston Scientific 73.68 Bn 73.14 Bn 3.85 Bn 2.67 Bn
5 Edwards Lifesciences 51.96 Bn 47.71 Bn 1.35 Bn 846.40 Mn
6 Dexcom 34.36 Bn 32.41 Bn 830.00 Mn 511.70 Mn
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn 1.44 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn -741.59 Mn
9 Steris 23.06 Bn 22.58 Bn 684.20 Mn 398.30 Mn
10 20 5.55 Mn 1.00 Mn 304,727.00 1.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.51 Mn
Mar 31, 2025 937,975.00